K-Ras is a signal transduction protein responsible for propagation of signals initiated by growth factors. Located downstream of EGFR it forms part of the Ras-Raf-MEK-ERK signalling pathway. k-Ras mutations are associated with many cancers – leukemias, lung cancers, colorectal and pancreatic cancers. Since tumors with activating mutations in k-Ras gene do not respond to Tyrosine Kinase Inhibitors (TKIs - anti-EGRF drugs) testing for k-Ras mutations provides a strategy to identify patients who are most likely to respond to anti-EGFR therapy.

​

Kras-MMD-PCR Mutation Test Kit enables in two closed-tube reactions detection of seven most common k-ras mutations in codons 12 and 13 against a background of wild-type genomic DNA.